Skip to main content
Log in

Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The aim of the present study was to determine the tolerance and efficacy of human brucellosis vaccine as well as the tolerance and sensitivity of the intradermal reaction test for brucellosis. A total of 1,121 subjects initially consented to participate in the study. Following clinical examination, 762 were tested with the intradermal reaction test (IDR Test, Pasteur Merieux, France), of whom 576 with no previous or current brucellosis infection were accepted for vaccination. Two hundred seventy-one were vaccinated with brucellosis vaccine and 305 with tetanus vaccine, the latter group serving as a comparative control group. The vaccinated persons were monitored monthly for at least nine months. Although brucellosis vaccine caused some unpleasant side effects in about one-fourth of the vaccinated persons, it appears safe for large-scale use in prevention programs. In addition, the results indicate that the intradermal reaction test is safe and sensitive for large-scale use in prevention programs. The test was positive in 28 of 30 individuals with previous infection, representing a sensitivity of 93.33 %.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Joint FAO/WHO Expert Committee on Brucellosis Sixth report of the Technical Report Series, No. 740. World Health Organization, Geneva, 1986.

    Google Scholar 

  2. Young EJ Human brucellosis. Reviews of Infectious Diseases 1983, 5: 821–842.

    PubMed  Google Scholar 

  3. Young EJ Brucellosis: a model zoonosis in developing countries. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1988, 3: 17–20.

    Google Scholar 

  4. Roux J Brucella vaccines in human. In: Monir Madkour M (ed): Brucellosis. University Press, Cambridge, 1989, p. 244–249.

    Google Scholar 

  5. Spink W, Hall J, Finstad J, Mallet E Immunization with viable brucella organisms. Bulletin of the World Health Organization 1962, 26: 409–419.

    PubMed  Google Scholar 

  6. Roux J La vaccination humaine contre les brucelloses. Bulletin de l' Academie Nationale de Medicine 1986, 170: 289–292.

    Google Scholar 

  7. Bentejac MC, Biron C, Bertrand A, Bascoul S Vaccination contre la Brucellose humaine bilan sur une periode de 2 ans. Developments in Biological Standarization 1984, 56: 531–535.

    Google Scholar 

  8. Roux J Les vaccinations dans les Brucelloses humaines et animales. Bulletin de l'Institut Pasteur 1972, 70: 145–202.

    Google Scholar 

  9. Roumiantzeff M, Colombet G, Joubert L, Desmettre PH Standarization sur l'animal delaboratoire d'une test intradermique destine a reveler l'hypersensibilite retardee brucellique chez l'home. Developments in Biological Standarization 1984, 56: 393–399.

    Google Scholar 

  10. Bertrand A, Siffert M, Bascoul S, Mathieu-Daude JC Interet pratique de la exploration de l'immunite cellulaire au cours de la Brucellose humaine. Developments in Biological Standarization 1984, 56: 537–546.

    Google Scholar 

  11. Bertrand A, Bentejac MC, Siffert M Utilisation chez l'homme d'un antigene phenolo-soluble Brucellien comme test de detection de la sensibilite cutanee specifique. Developments in Biological Standarization 1984, 56: 547–551.

    Google Scholar 

  12. Manetas S: Epidemiological investigation of brucellosis in three provinces of Greece. Thesis, University of Athens, 1984.

  13. Jeffery P, Taylor JP, Perdue JN The changing epidemiology of human brucellosis in Texas, 1977–1986. American Journal of Epidemiology 1989, 130: 160–165.

    PubMed  Google Scholar 

  14. Heizmann W, Botzenhart K, Doller G Brucellosis: serological methods compared. Journal of Hygiene (Cambridge) 1985, 95: 639–653.

    PubMed  Google Scholar 

  15. Araj GF Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. Journal of Hygiene (Cambridge) 1986, 97: 457–469.

    PubMed  Google Scholar 

  16. Lopez-Merino A, López-Santiago R Immunology of brucellosis in humans. In: Monir Madkour M (ed): Brucellosis. University Press, Cambridge, 1989, p. 244–249.

    Google Scholar 

  17. Krambovitis E, Tselentis J, Tsoukatos D A simple enzyme immunoassay for detecting brucellosis antibodies. FEMS Microbiology Immunology 1992, 89: 129–136.

    Article  Google Scholar 

  18. Duclos PJ, Bentejac KC, Serre A, Bascoul S Skin test reactions to a phenol-soluble antigen ofBrucella abortus among veterinary students, Lyon, France, 1984. International Journal of Epidemiology 1989, 18: 446–450.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hadjichristodoulou, C., Voulgaris, P., Toulieres, L. et al. Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis. Eur. J. Clin. Microbiol. Infect. Dis. 13, 129–134 (1994). https://doi.org/10.1007/BF01982185

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01982185

Keywords

Navigation